UK accuses drugmakers and distributor of non-compete agreements
The UK’s competition enforcer has provisionally found that four companies agreed not to compete in the supply of an anti-nausea tablet to the country’s national health service, resulting in a 700% rise in the price.
To read more
Subscribe to Global Competition Review
Subscribe and start reading now
Global Competition Review (GCR) is a leading global provider of competition law, regulation and enforcement information, combining data, deep market insight and a user-centric platform to provide our clients with powerful legal solutions.
Already have access? Login below
Copyright © Law Business ResearchCompany Number: 03281866 VAT: GB 160 7529 10